Lipidor AB
Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.
LIPI | ST
Overview
Corporate Details
- ISIN(s):
- SE0012558617 (+1 more)
- LEI:
- 549300OC9DDXCE1GMX60
- Country:
- Sweden
- Address:
- C/O Ekonomistubben AB, 102 16 Stockholm
- Website:
- https://lipidor.se/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Lipidor AB is a pharmaceutical research and development company specializing in topical treatments for skin diseases. The company's core asset is its proprietary lipid-based drug delivery platform, AKVANO®. Lipidor's business model focuses on reformulating existing active pharmaceutical ingredients into new, innovative, and patient-friendly treatments. This approach offers an accelerated path to regulatory approval and commercialization for its global pharmaceutical partners. The AKVANO® platform is designed to enhance patient compliance by creating formulations that are easy to apply, quick-drying, and less likely to cause skin irritation. The company maintains a pipeline of development projects in various pre-clinical and clinical phases for a wide range of dermatological conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Date | Filing | Language | Size | Actions | |
---|---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all Lipidor AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Lipidor AB via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |